Global Induced Pluripotent Stem Cells Market By Derived Cell Type (Fibroblasts, Hepatocytes, Keratinocytes, Amniotic Cells, and Others), By Application (Drug Development, Disease Modeling, Toxicology Research, and Tissue Engineering & Regenerative Medicine (Orthopedics, Oncology, Neurology, Diabetes, Cardiovascular and Myocardial Infarction, and Others)), By End-user (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151546
- Number of Pages: 221
- Format:
-
-
-
- Takara Bio, Inc
- STEMCELL Technologies Inc
- REPROCELL Inc
- Fate Therapeutics, Inc
- Evotec SE
- Cynata Therapeutics Limited
- Shinobi
- Axol Bioscience Ltd
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |